These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 944951)

  • 41. Effects of alpha-methylphenylalanine plus phenylalanine treatment during development on myelin in rat brain.
    Johnson RC; Shah SN
    Neurochem Res; 1980 Jul; 5(7):709-18. PubMed ID: 7422057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dietary induction of hyperphenylalaninemia in the rat.
    Kerr GR; Waisman HA
    J Nutr; 1967 May; 92(1):10-8. PubMed ID: 6067644
    [No Abstract]   [Full Text] [Related]  

  • 43. [Determination of phenylalanine hydroxylase in patients with phenylketonuria and hyperphenylalaninemia].
    Bartholomé K; Lutz P
    Monatsschr Kinderheilkd (1902); 1976 May; 124(5):421-2. PubMed ID: 934137
    [No Abstract]   [Full Text] [Related]  

  • 44. Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria.
    Kaufman S; Berlow S; Summer GK; Milstien S; Schulman JD; Orloff S; Spielberg S; Pueschel S
    N Engl J Med; 1978 Sep; 299(13):673-9. PubMed ID: 683251
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of phenylalanine hydroxylase activity in patients with phenylketonuria and hyperphenylalaninemia.
    Bartholomé K; Lutz P; Bickel H
    Pediatr Res; 1975 Dec; 9(12):899-903. PubMed ID: 1196708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of dietary mixtures of amino acids on fetal growth and maternal and fetal amino acid pools in experimental maternal phenylketonuria.
    Austic RE; Su CL; Strupp BJ; Levitsky DA
    Am J Clin Nutr; 1999 Apr; 69(4):687-96. PubMed ID: 10197570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amino acid depletion in the blood and brain tissue of hyperphenylalaninemic rats is abolished by the administration of additional lysine: a contribution to the understanding of the metabolic defects in phenylketonuria.
    Huether G; Kaus R; Neuhoff V
    Biochem Med; 1985 Jun; 33(3):334-41. PubMed ID: 3925942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of cerebral catecholamine concentrations during hyperphenylalaninaemia.
    Brass CA; Greengard O
    Biochem J; 1982 Dec; 208(3):765-71. PubMed ID: 7165732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemia.
    Castillo M; Zafra MF; Garcia-Peregrin E
    Neurochem Res; 1988 Jun; 13(6):551-5. PubMed ID: 3405380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma biopterin levels and tetrahydrobiopterin responsiveness.
    Shintaku H; Fujioka H; Sawada Y; Asada M; Yamano T
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S104-6. PubMed ID: 16183315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultrastructural changes in rat optic nerve associated with hyperphenylalaninemia induced by para-chlorophenylalanine and phenylalanine.
    Avins L; Guroff G; Kuwabara T
    J Neuropathol Exp Neurol; 1975 Mar; 34(2):178-88. PubMed ID: 123574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experimentally induced phenylketonuria. 4. Potential inhibitors of phenylalanine hydroxylase.
    DeGraw JI; Brown VH; Skinner WA; Le Valley S; Mitomac
    J Med Chem; 1972 Jul; 15(7):781. PubMed ID: 5065129
    [No Abstract]   [Full Text] [Related]  

  • 53. Hyperphenylalaninemia in a premature infant with heterozygosity for phenylketonuria.
    Hennermann JB; Loui A; Weber A; Mönch E
    J Perinat Med; 2004; 32(4):383-5. PubMed ID: 15346830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria.
    Hennermann JB; Bührer C; Blau N; Vetter B; Mönch E
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S86-90. PubMed ID: 16051511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The isolation and properties of phenylalanine hydroxylase from human liver.
    Woo SL; Gillam SS; Woolf LI
    Biochem J; 1974 Jun; 139(3):741-9. PubMed ID: 4854919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenylalanine ammonia-lyase immobilized in microcapsules for the depletion of phenylalanine in plasma in phenylketonuric rat model.
    Bourget L; Chang TM
    Biochim Biophys Acta; 1986 Oct; 883(3):432-8. PubMed ID: 3756210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. beta-2-Thienyl-DL-alanine as an inhibitor of phenylalanine hydroxylase and phenylalanine intestinal transport.
    Wapnir RA; Moak GS
    Biochem J; 1979 Jan; 177(1):347-52. PubMed ID: 570838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Determination of phenylalanine-4-hydroxylase as a parameter in the differential diagnosis of hyperphenylalaninemia].
    Kukla L; Mrskos A; Pijácková A; Podhradská O
    Cesk Pediatr; 1987 Sep; 42(9):542-5. PubMed ID: 3664770
    [No Abstract]   [Full Text] [Related]  

  • 59. Behavioral effects of experimental maternal hyperphenylalaninemia.
    Schalock RL; Copenhaver JH
    Dev Psychobiol; 1973 Nov; 6(6):511-20. PubMed ID: 4272316
    [No Abstract]   [Full Text] [Related]  

  • 60. [In-vivo studies on the activation possibility of the phenylalanine hydroxylase system in hyperphenylalaninemia through treatment with pterins].
    Grimm U; Knapp A; Haufe F
    Acta Biol Med Ger; 1976; 35(5):675-8. PubMed ID: 988698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.